NLS Pharmaceutics (NLSP) 20-F2023 FY Annual report (foreign)

Filed: 15 May 24, 4:02pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: addendum, Aexon, Aknin, Allouch, Allouche, Amyotrophic, Anthony, ASCP, Audrey, automating, Avista, Bachelor, Bassetti, Bern, bid, bioinnovation, biologist, biomanufacturing, bound, breadth, Bundesrat, Calcog, Caligor, career, CARF, CBM, CCPA, Chair, Chairwoman, Claudio, Clawback, Coghlan, compliant, CPA, creditor, CRO, cyber, Dean, degenerative, DEI, delete, diversifying, divestment, Docket, Eastern, Elena, email, endeavor, erosion, Erroneously, escalation, etiology, explain, Faculty, FDAFDA, Florence, fluctuate, Forecast, fundamental, Gallen, GBP, Greenberg, hearing, HEC, hereto, holistic, Huntington, inconsistent, Influential, Inselspital, insourcing, intrusion, ischemic, Israel, Ladle, Lausanne, Lumryz, magazine, mentor, Mercure, Miami, Microsoft, military, multinational, Myrpharm, neuro, Neurocenter, neurophysiology, nightly, online, overdue, Panel, Parkinson, penny, PepKon, Pharmacy, Philly, pinpointing, pioneered, Player, popular, post, professor, prompt, PRSA, Psychopharmacology, QDMTT, ready, refinancing, regain, renowned, rest, Revolutionary, routine, Russia, Schweizerische, shifting, Sorbonne, Southern, SOX, spanning, St, store, stored, stricter, studio, subcontractor, super, switching, tabletop, tech, theft, threat, Titan, Trailblazer, Tribune, unlock, version, viability, Walsh, Wharton, Woman, Women, Young

Removed: Aalborg, AB, Assistant, biochemistry, built, cap, Catacap, CHEMM, ChemoMetec, computer, Copenhagen, Danish, Diagnostika, Directive, discussing, Econ, Friedrich, ImVisioN, Julier, Kwon, leased, leaving, LLP, Lokke, LUN, Lundbeck, Marcum, MGNX, Miescher, mitigate, MSc, Nextech, noticed, NUE, Nuevolution, observer, Pedersen, Planner, PMG, repay, sensitive, SSI, Stemform, Stig, subordinated, systemic, TAP, Telormedix, TRACON, unexpectedly, unnecessary, unsuccessful, USA, vulnerable

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

NLSP similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 15.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form F-3 (No. 333-262489, No. 333-268690 and No. 333-269220) of NLS Pharmaceutics Ltd. of our report dated May 15, 2024 relating to the financial statements, which appears in this Form 20-F.

/s/ PricewaterhouseCoopers AG
Zurich, Switzerland
May 15, 2024

PricewaterhouseCoopers AG, Birchstrasse 160, Postfach, CH-8050 Zurich, Switzerland

Telefon: +41 58 792 44 00, Telefax: +41 58 792 44 10, www.pwc.ch

PricewaterhouseCoopers AG is a member of the global PricewaterhouseCoopers network of firms, each of which is a separate and independent legal entity.